European Companies Search Engine
Word figurative mark: “argenx“ Euipotm8 Apr 2024 European Union Intellectual Property Office (Trade Marks)
History
Text
Trade mark
| Type | Figurative |
| Name | argenx |
| Graphic representation |  |
| Filing number | 018802240 |
| Trade mark status | REGISTERED |
| Nice Classification |
5: Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system. 35: Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; Administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs. 42: Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development. 44: Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; Provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network. |
| Filing date | 25/11/2022 |
| Registration date | 04/04/2024 |
| Expiry date | 25/11/2032 |
| Owners |
B-9052 Zwijnaarde Belgium |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Argenx B.V., Ghent, Belgium.